This Simplicity Summit session will explore the evolving trajectory of diabetes management with a focus on Linagliptin, highlighting its unique clinical profile, renal safety, and long-term efficacy. The discussion will include the role of DPP-4 inhibitors in simplifying diabetes care, optimizing glycemic control, and addressing comorbidities such as renal impairment. The program will conclude with an interactive Q&A, offering practical insights and real-world perspectives from leading experts.